SCHEMBL31023925

SCHEMBL31023925

O=C(Oc1ccc(Oc2ccccc2)cc1)N1CCN(C(c2ccc3c(c2)COCO3)c2ccc3c(c2)COCO3)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 8/20 0.56
USP2 O75604 3/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
CYP2C9 P11712 2/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP2D6 P10635 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
HIF1A Q16665 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.40
KMT2A Q03164 3/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.39
CASP3 P42574 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023923 1.00 MGLL (0.56) MGLLUSP2CYP3A4CYP1A2HSD17B10
SCHEMBL31023889 0.88 MGLL (0.46) MGLLUSP2CYP3A4CYP1A2SMN1; SMN2
SCHEMBL31023970 0.88 MGLL (0.55) MGLLUSP2CYP3A4CYP1A2
SCHEMBL31023721 0.85 MGLL (0.62) MGLLCYP1A2CYP2D6FAAH
SCHEMBL31023644 0.84 SMN1; SMN2 (0.54) MGLLUSP2CYP3A4CYP1A2HSD17B10
SCHEMBL31023695 0.82 MGLL (0.42) MGLLUSP2CYP3A4CYP1A2ALDH1A1
SCHEMBL31023825 0.81 MGLL (0.40) MGLL
SCHEMBL31023723 0.81 SMAD3 (0.42) MGLLALDH1A1KMT2AKDM4EMEN1
SCHEMBL31023944 0.79 SCD5 (0.44) MGLLUSP2CYP3A4NPC1RAB9A
SCHEMBL31023763 0.78 MGLL (0.59) MGLLALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed